Your session is about to expire
← Back to Search
Human Milk Derived Fortifier for Congenital Heart Defects
Study Summary
This trial will evaluate the benefits of an exclusive human milk diet for infants with single ventricle physiology.
- Congenital Heart Defects
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many medical centers are engaged in this investigation?
"This clinical trial is utilizing the medical facilities at University of Texas Southwestern Medical Center in Dallas, Loma Linda University in California and Texas Children's Hospital in Houston as well as 10 other sites."
Are any new participants being enrolled for this experiment?
"This trial, which was posted on the 1st of July 2016 and most recently modified October 10th 2022, is not presently recruiting. Fortunately, there are other 108 studies actively accepting participants currently listed on clinicaltrials.gov."
What are the eligibility requirements for participation in this trial?
"This clinical investigation is looking to enrol 16 neonates with congenital heart malformations, ranging from day-old infants up to 7 days old. Applicants must satisfy the following requirements: Have a gestational age of at least 37 weeks 0/7; Be fed by either only mothers' milk or nothing prior to enrollment; Allow parental consent for the trial and compliance with follow-up protocols; Require their single ventricle defect be palliated surgically within one month of birth."
Does the age requirement for this medical trial cap at 45 years old?
"As stated in the study requirements, infants between 1 and 7 days old are eligible to take part."
Share this study with friends
Copy Link
Messenger